Garry L. Morefield, Ph.D. - Publications

Affiliations: 
2003 Purdue University, West Lafayette, IN, United States 
Area:
Immunology, Pharmacy

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Troese MJ, Burlet E, Cunningham MW, Alvarez K, Bentley R, Thomas N, Carwell S, Morefield GL. Group A Streptococcus Vaccine Targeting the Erythrogenic Toxins SpeA and SpeB Is Safe and Immunogenic in Rabbits and Does Not Induce Antibodies Associated with Autoimmunity. Vaccines. 11. PMID 37766180 DOI: 10.3390/vaccines11091504  0.419
2017 Burlet E, HogenEsch H, Dunham A, Morefield G. Evaluation of the Potency, Neutralizing Antibody Response, and Stability of a Recombinant Fusion Protein Vaccine for Streptococcus pyogenes. Aaps Journal. 19: 875-881. PMID 28283948 DOI: 10.1208/S12248-017-0069-5  0.465
2016 HogenEsch H, Dunham A, Burlet E, Lu F, Mosley YC, Morefield G. Preclinical safety study of a recombinant Streptococcus pyogenes vaccine formulated with aluminum adjuvant. Journal of Applied Toxicology : Jat. PMID 27241723 DOI: 10.1002/Jat.3349  0.466
2014 Morefield G, Touhey G, Lu F, Dunham A, HogenEsch H. Development of a recombinant fusion protein vaccine formulation to protect against Streptococcus pyogenes. Vaccine. 32: 3810-5. PMID 24837509 DOI: 10.1016/J.Vaccine.2014.04.092  0.514
2011 Morefield GL. A rational, systematic approach for the development of vaccine formulations. The Aaps Journal. 13: 191-200. PMID 21347616 DOI: 10.1208/S12248-011-9261-1  0.436
2008 Morefield GL, Tammariello RF, Purcell BK, Worsham PL, Chapman J, Smith LA, Alarcon JB, Mikszta JA, Ulrich RG. An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock. Journal of Immune Based Therapies and Vaccines. 6: 5. PMID 18768085 DOI: 10.1186/1476-8518-6-5  0.458
2007 Morefield GL, Hawkins LD, Ishizaka ST, Kissner TL, Ulrich RG. Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome. Clinical and Vaccine Immunology : Cvi. 14: 1499-504. PMID 17715328 DOI: 10.1128/Cvi.00153-07  0.443
2006 Jiang D, Morefield GL, HogenEsch H, Hem SL. Relationship of adsorption mechanism of antigens by aluminum-containing adjuvants to in vitro elution in interstitial fluid. Vaccine. 24: 1665-9. PMID 16246468 DOI: 10.1016/J.Vaccine.2005.09.048  0.583
2005 Morefield GL, Sokolovska A, Jiang D, HogenEsch H, Robinson JP, Hem SL. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine. 23: 1588-95. PMID 15694511 DOI: 10.1016/J.Vaccine.2004.07.050  0.588
2005 Morefield GL, Jiang D, Romero-Mendez IZ, Geahlen RL, Hogenesch H, Hem SL. Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid. Vaccine. 23: 1502-6. PMID 15670886 DOI: 10.1016/J.Vaccine.2004.08.048  0.532
2004 Morefield GL, HogenEsch H, Robinson JP, Hem SL. Distribution of adsorbed antigen in mono-valent and combination vaccines. Vaccine. 22: 1973-84. PMID 15121310 DOI: 10.1016/J.Vaccine.2003.10.040  0.603
2002 Dandashli EA, Zhao Q, Yitta S, Morefield GL, White JL, Hem SL. Effect of thermal treatment during the preparation of aluminum hydroxide adjuvant on the protein adsorption capacity during aging. Pharmaceutical Development and Technology. 7: 401-6. PMID 12503522 DOI: 10.1081/Pdt-120015042  0.518
Show low-probability matches.